Company
Syndax (NASDAQ: SNDX)
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before.
Also known as Syndax
- Business model
- B2B
- syndax.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Record updated 28 September 2026
About
Syndax’s mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.